tetano
Editor, Senior Moderator
3 Biotech
. 2022 Sep;12(9):240.
doi: 10.1007/s13205-022-03286-0. Epub 2022 Aug 23.
Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses
Avinash Kumar[SUP] 1 [/SUP], Ekta Rathi[SUP] 1 [/SUP], Suvarna Ganesh Kini[SUP] 1 2 [/SUP]
Affiliations
Abstract
Spike (S) proteins are an attractive target as it mediates the binding of the SARS-CoV-2 to the host through ACE-2 receptors. We hypothesize that the screening of the S protein sequences of all the seven known HCoVs would result in the identification of potential multi-epitope vaccine candidates capable of conferring immunity against various HCoVs. In the present study, several machine learning-based in-silico tools were employed to design a broad-spectrum multi-epitope vaccine candidate targeting the S protein of seven known strains of human coronaviruses. Herein, multiple B-cell epitopes and T-cell epitopes (CTL and HTL) were predicted from the S protein sequences of all seven known HCoVs. Post-prediction they were linked together with an adjuvant to construct a potential broad-spectrum vaccine candidate. Secondary and tertiary structures were predicted and validated, and the refined 3D-model was docked with an immune receptor. The vaccine candidate was evaluated for antigenicity, allergenicity, solubility, and its ability to achieve high-level expression in bacterial hosts. Finally, the immune simulation was carried out to evaluate the immune response after three vaccine doses. The designed vaccine is antigenic (with or without the adjuvant), non-allergenic, binds well with TLR-3 receptor and might elicit a diverse and strong immune response.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-022-03286-0.
Keywords: Cheminformatics; Coronaviruses; Covid-19; Immunoinformatic; SARS-CoV-2; Vaccine.
. 2022 Sep;12(9):240.
doi: 10.1007/s13205-022-03286-0. Epub 2022 Aug 23.
Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses
Avinash Kumar[SUP] 1 [/SUP], Ekta Rathi[SUP] 1 [/SUP], Suvarna Ganesh Kini[SUP] 1 2 [/SUP]
Affiliations
- PMID: 36003896
- PMCID: PMC9395775
- DOI: 10.1007/s13205-022-03286-0
Abstract
Spike (S) proteins are an attractive target as it mediates the binding of the SARS-CoV-2 to the host through ACE-2 receptors. We hypothesize that the screening of the S protein sequences of all the seven known HCoVs would result in the identification of potential multi-epitope vaccine candidates capable of conferring immunity against various HCoVs. In the present study, several machine learning-based in-silico tools were employed to design a broad-spectrum multi-epitope vaccine candidate targeting the S protein of seven known strains of human coronaviruses. Herein, multiple B-cell epitopes and T-cell epitopes (CTL and HTL) were predicted from the S protein sequences of all seven known HCoVs. Post-prediction they were linked together with an adjuvant to construct a potential broad-spectrum vaccine candidate. Secondary and tertiary structures were predicted and validated, and the refined 3D-model was docked with an immune receptor. The vaccine candidate was evaluated for antigenicity, allergenicity, solubility, and its ability to achieve high-level expression in bacterial hosts. Finally, the immune simulation was carried out to evaluate the immune response after three vaccine doses. The designed vaccine is antigenic (with or without the adjuvant), non-allergenic, binds well with TLR-3 receptor and might elicit a diverse and strong immune response.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-022-03286-0.
Keywords: Cheminformatics; Coronaviruses; Covid-19; Immunoinformatic; SARS-CoV-2; Vaccine.